Thanks to both of your responses in helping us understand the MACE event rate better.
Question: Is the primary endpoint of our trial to achieve 30% RRR or is it just to be better than the existing standard of care.... ie would 10%-15% RRR qualify as making the primary endpoint,..?
Thanks!